Green Thumb Industries (GTBIF) Liabilities and Shareholders Equity (2019 - 2026)

Green Thumb Industries (GTBIF) posted Liabilities and Shareholders Equity of $2.8 billion for Q1 2026, up 1.49% on a QoQ basis from $2.8 billion in Q4 2025, and up 10.22% year-over-year from $2.6 billion in Q1 2025.

Green Thumb Industries (GTBIF) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Green Thumb Industries' Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $2.8 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 10.22% year-over-year to $2.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 billion (up 6.37% YoY) and the FY2025 annual result came in at $2.8 billion, up 9.97% from the prior year.
  • Liabilities and Shareholders Equity was $2.8 billion for Q1 2026 at Green Thumb Industries, up from $2.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.8 billion in Q1 2026 and bottomed at $2.4 billion in Q1 2022.
  • A 5-year average of $2.5 billion and a median of $2.5 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 54.74% — and 2025, when it advanced 0.3%.
  • Green Thumb Industries' Liabilities and Shareholders Equity stood at $2.4 billion in 2022, then gained by 2.32% to $2.5 billion in 2023, then gained by 1.89% to $2.5 billion in 2024, then rose by 9.97% to $2.8 billion in 2025, then grew by 1.49% to $2.8 billion in 2026.
  • Business Quant data shows GTBIF's Liabilities and Shareholders Equity at $2.8 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn 2.83 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.83 Bn
Dec 31, 2025 2.79 Bn
Sep 30, 2025 2.64 Bn
Jun 30, 2025 2.55 Bn
Mar 31, 2025 2.57 Bn
Dec 31, 2024 2.54 Bn
Sep 30, 2024 2.51 Bn
Jun 30, 2024 2.54 Bn
Mar 31, 2024 2.55 Bn
Dec 31, 2023 2.49 Bn
Sep 30, 2023 2.50 Bn
Jun 30, 2023 2.51 Bn
Mar 31, 2023 2.49 Bn
Dec 31, 2022 2.43 Bn
Sep 30, 2022 2.46 Bn
Jun 30, 2022 2.44 Bn
Mar 31, 2022 2.40 Bn
Dec 31, 2021 2.39 Bn
Sep 30, 2021 2.15 Bn
Jun 30, 2021 1.79 Bn